The data from the present study demonstrated that CA and Res could amend ROS production, mitochondrial-mediated apoptosis, and p53 and NF-κB activation in both tBH-treated Drosophila and human neuroblastoma cell models of SCA3. The gene discussed is NFKB1; the disease is Spinocerebellar ataxia type 3.